- $6.28bn
- $8.29bn
- $5.45bn
- 65
- 86
- 54
- 77
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 4,528 | 4,739 | 5,121 | 5,227 | 5,448 |
Losses, Benefits, and Adjustments | |||||
Amortization of Policy Acquisition Costs | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,512 | 3,755 | 3,763 | 4,034 | 4,151 |
Operating Profit | 1,016 | 983 | 1,358 | 1,193 | 1,297 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 931 | 897 | 1,275 | 1,102 | 1,194 |
Provision for Income Taxes | |||||
Net Income After Taxes | 761 | 732 | 1,031 | 894 | 971 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 761 | 732 | 1,031 | 894 | 971 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 761 | 732 | 1,031 | 894 | 971 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.9 | 6.85 | 10.1 | 9.06 | 10.1 |
Dividends per Share |